Serum Cystatin C: A Potential Biomarker in Pediatric PAH

Written By: user

IJCP Editorial Team

Published On: 15 Apr, 2023 4:05 PM | Updated On: 16 May, 2024 6:19 AM

Serum Cystatin C: A Potential Biomarker in Pediatric PAH

Cystatin C – a crucial marker of heart failure (HF), strongly correlates to right ventricle (RV) ejection fraction (EF). Therefore, it may also be useful in determining pulmonary arterial hypertension (PAH) among pediatric patients.

A new study evaluated the utility of cystatin C as a biomarker in the diagnosis and prognosis of PAH.

This study recruited 22 children with PAH and 19 matched controls from December 2017-May, 2018. Patients were investigated for their serum-ProBNP levels and cystatin C. Echocardiography was employed to detect – RV-EF, RV end-systolic volume, RV-Tei index, RV end-diastolic volume Tricuspid Annular Plane Systolic Excursion (TAPSE), and left ventricle (LV) eccentricity.

The results showed that the serum-cystatin-C levels of PAH patients were higher than those of the controls. The primary PAH group showed greater Cystatin-C levels compared to the Eisenmenger syndrome and control groups. Meanwhile, PAH patients had lower RV-EF and TAPSE and higher LV eccentricity measurements.

Children with PAH exhibit normal glomerular filtration rate (GFR) and high cystatin C levels. It was concluded that cystatin C could be a useful biomarker for specifying RV dysfunction in this group of patients, owing to its correlation with the RV Tei index. Cystatin C can be deemed as a potential new biomarker in PAH.

Source: Indian Journal of Pediatrics. 2023 Apr;90(4):417.

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.